California has just taken a bold step in the fight for women’s reproductive rights in the United States.
Its lawmakers have passed one of the strongest measures aimed at protecting health care providers who distribute abortion pills to states where abortion is banned, as well as the patients who receive them.
According to a report by the San Francisco Examiner, the bill sailed through the State Assembly and Senate last week with overwhelming support and is poised for approval by Governor Gavin Newsom. What makes this legislation particularly significant is its provision allowing health care providers to mail abortion pills while minimizing identifying information – the labels and paperwork can exclude the names of the patient, the prescriber and the pharmacist.
This new law is expected to greatly affect the majority of the country since most medication abortion services depend on pharmacies in California to supply and distribute the medication. They are also designed to make it harder for states where abortion is banned to take legal action against doctors and healthcare providers who are protected by shield laws.
Shield laws were created in response to the Supreme Court’s decision to eliminate the national right to abortion, providing safety for those who prescribe abortion pills. These laws are intended to reassure women who might be worried about getting prescription pills due to fears of being monitored or identified by authorities, creating a sense of safety and privacy for those seeking care.
To date, in at least eight states, the laws stop officials from following subpoenas, extradition requests and other legal actions that states with abortion bans use against abortion providers. This is a major shift from the usual way states work together on legal issues and they have been an important source of abortion access for women. They are currently helping around 12,000 patients each month, which is about one-eighth of all abortion patients in the country. As the number of patients using these providers has increased, opponents of abortion in these states have started to file civil lawsuits and criminal charges. One notable case involves a showdown between Texas and New York, which could lead to a constitutional battle likely to reach the Supreme Court.
In response to the growing legal challenges, several states, including New York, Washington and Massachusetts, have recently enacted laws allowing doctors to send abortion pills with just the name of their medical practice on the packages, rather than their personal names. However, since many of these providers use pharmacies in California to ship the pills, they’ve had to comply with California’s rule that requires the prescriber’s name to be listed on the bottle.
This new law aims to change that.
“Because California is such a hub for this, we needed to take it a step further,” said Jessica Nouhavandi, a California pharmacist who helped with the legislation, in an interview with The New York Times. “Protecting just one piece of the puzzle wasn’t enough.”
According to Natalie Birnbaum, the state legal and policy director for the Reproductive Health Initiative for Telehealth Equity and Solutions, pharmacists and prescribers will still be required to maintain detailed records, including the patient’s name and other standard prescription details. However, the bill introduces a streamlined approach for abortion patients, allowing them to receive a “bare bones” label that simply states the name of the medication, instructions for use and a contact number for any inquiries.
“Having a patient’s name on the label of abortion medication is stopping people from receiving the care they need,” she said. Even though state laws don’t punish the patients, “there is still confusion, fear, and a growing stigma around abortion.”
Ameet Sarpatwari, an assistant professor of medicine at Harvard Medical School, agrees. He told The Times that “patient names have historically been on prescriptions and packaging to safeguard safety and prevent misuse and abuse.” But, he explained that considering how the new bill is limited to abortion medication, and many studies have shown that abortion pills are safe, the California measure “doesn’t really raise fears.”
Brigid Groves, the vice president of professional affairs for the American Pharmacists Association, voiced valid concerns about giving out medications that don’t have patients’ names on them. She underscored that it’s critical to make sure “the right patient at the right time is getting that.”
Her organization hasn’t taken a definitive stance on the California bill and she questions the potential slippery slope of establishing exceptions for specific medication classes. “If we start this process or this exclusion for one class of medications, how far does that go?” she said.
Still, when it comes to abortion pills, Groves acknowledged the delicate balance between patient safety and privacy.
“I understand wanting to make sure that in this case, people aren’t being targeted or going to have other repercussions because of the medication they’ve been prescribed.”
